High mobility group nucleosomal binding domain 2 pseudogene 26 (HMGN2P26)

High mobility group nucleosomal binding domain 2 pseudogene 26 (HMGN2P26) is a processed pseudogene in the human genome. It is so named because its sequence closely resembles that of the active HMGN2 gene, which encodes a member of the high mobility group nucleosome-binding protein family. These proteins (functional analogues, not the pseudogene itself) influence chromatin architecture, epigenetic regulation, and gene expression. HMGN family members (such as HMGN1 and HMGN2) are involved in differentiation and development and modulate chromatin compaction. However, HMGN2P26 is not expressed as a protein, does not code for a functional product, and has no established biological function or disease involvement. Like other pseudogenes, HMGN2P26 may theoretically exert regulatory effects (for example, acting as a competing endogenous RNA or a source of small RNAs), but there is no direct evidence to support such a functional role for this specific locus in humans. Pseudogenes as a class may influence gene regulation by serving as miRNA sponges, sources of siRNAs, or regulators of their parental or related functional genes, but this is not universal and often remains speculative without direct experimental confirmation. The parent genes of the HMGN family are chromatin architectural proteins involved in a variety of developmental and cellular processes, but these roles do not extend to the HMGN2P26 pseudogene. HMGN2P26 is a processed pseudogene with no known functional protein product, disease association, or drug interaction. It is not a therapeutic target.

Other names

HMGN2P26high mobility group nucleosomal binding domain 2 pseudogene 26

None known for HMGN2P26.